Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT01905878

Biological Half Life of DLBS1033 in Healthy Volunteers

Sponsor: Dexa Medica Group

Interventions DLBS1033

Updated 6 times since 2017 Last updated: May 11, 2017 Started: Jun 30, 2013 Primary completion: Sep 30, 2013 Completion: Dec 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01905878, this PHASE1/PHASE2 trial focuses on Healthy Condition and remains completed. Sponsored by Dexa Medica Group, it has been updated 6 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Jun 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

Status: Unknown Status → Completed

▶ Show 1 earlier version

Jan 2017 — Jun 2017 [monthly]

Unknown Status PHASE1_PHASE2

First recorded

Jun 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dexa Medica Group
Indonesia University

Data source: Indonesia University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jakarta, Indonesia